Lorlatinib, sold under the brand name Lorlatini,Lorbrena among others in the United States, Canada, and Japan,…
Mobocertinib is a small molecule tyrosine kinase inhibitor. Its molecular target is epidermal growth factor receptor (EGFR) bearing mutations in…
Ceritinib is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). Non-Small Cell Lung…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Aentrek(entrectinib) is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults…
[Indications] Giefoni is a tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with…
[Indications] It is used for the treatment of advanced patients with metastatic non-small cell lung cancer…